Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Guelinckx I. et al. Maternal obesity: pregnancy complications, gestational weight gain and nutrition // Obesity Reviews. — 2008. — Vol. 9. — P. 140-150.
Bodnar L.M. et al. The risk of preeclampsia rises with increasing prepregnancy body mass index // Annals of Epidemio-logy. — 2005. — Vol. 15(7). — P. 475-482.
Kristensen J. et al. Pre-pregnancy weight and the risk ot stillbirth and neonatal death // BJOG: An International Journal of Obstetrics and Gynaecology. — 2005. — Vol. 112(4). — P. 403-408.
Sirimi N., Goulis D.G. Obesity in pregnancy // Hormones. — 2010. — Vol. 9(4). — P. 299-306.
Challier J., Galtier M., Bintein T. et al. Placental leptin receptor isoforms in normal and pathological pregnancies // Placenta. — 2003. — Vol. 24. — P. 92-99.
Weiwei T., Haiyan T., Juan C. et al. Expressions of adiponectin receptors in placenta and their correlation with preeclampsia // Reprod. Sci. — 2009. — Vol. 16. — P. 676-684.
McDonald E.A., Wolfe M.W. The pro-inflammatory role of adiponectin at the maternal-fetal interface // Am. J. Reprod. Immunol. — 2011. — Vol. 66. — P. 128-136.
Ouchi N., Kobayashi H., Kihara S. et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated proteinkinase and Akt signaling in endothelial cells // J. Biol. Chem. — 2004. — Vol. 279. — P. 1304-1309.
Jarvenpaa J., Vuoristo J.T., Santaniemi M. et al. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR // J. Perinat. Med. — 2009. — Vol. 37. — P. 257-262.
Amaluddin M.S., Weakley S.M., Yao Q., Chen C. Resistin: functional roles and therapeutic considerations for cardiovascular disease // Br. J. Pharmacol. — 2012. — Vol. 165(3). — P. 622-632.
Miehle K., Holger S., Fasshauer M. Leptin, Adiponectin and other Adipokines in Gestational Diabetes Mellitus and Pre-eclampsia // Clin. Endocrinol. — 2012. — Vol. 76(1). — P. 2-11.
Misra V.K., Trudeau S. The Influence of Overweight and Obesity on Longitudinal Trends in Maternal Serum Leptin Levels During Pregnancy // Obesity. — 2011. — Vol. 192. — P. 416-421.
Catalano P.M., Hoegh M., Minium J. et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism // Diabetologia. — 2006. — Vol. 49. — P. 1677-1685.
Kajantie E, Hytinantti T., Hovi P. et al. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term // Journal of Clinical Endocrinology and Metabolism. — 2004. — Vol. 89. — P. 4031-4036.
Chen J., Tan B., Karteris E. et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines // Diabetologia. — 2006. — Vol. 49. — P. 1292-1302.
Nien J.K., Mazaki-Tovi S., Romero R. et al. Resistin: a hormone which induces insulin resis¬tance is increased in normal pregnancy // Journal of Perinatal Medicine. — 2007. — Vol. 35. — P. 513-521.
Mazaki-Tovi S., Romero R., Kusanovic J.P. et al. Maternal visfatin concentration in normal pregnancy. // Journal of Perinatal Medicine. — 2009. — Vol. 37. — P. 206-217.
Ognjanovic S., Tashima L.S., Bryant-Greenwood G.D. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis // American Journal of Obstetrics and Gynecology. — 2003. — Vol. 189. — P. 1187-1195.
Vaisbuch E., Mazaki-Tovi S., Kusanovic J.P. et al. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation // The Journal of Maternal-Fetal and Neonatal Medicine. — 2010. — Vol. 23. — P. 111-119.
Ueland T., Dalsoren T., Voldner N. et al. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. // European Journal of Endocrinology — 2008. — Vol. 159. — P. 49-54.
Inoue S., Takamoto N., Akahori Y. et al. Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension // The Journal of Obstetrics and Gynaecology Research. — 2009. — Vol. 35. — P. 293-300.
Esakoff T.F., Cheng Y.W., Sparks T.N., Caughey A.B. The association between birthweight 4000 gm or greater and perinatal outcomes in patients with and without gestational diabetes mellitus // Am. J. Obstet. Gynecol. — 2009. — Vol. 672. — E1-E4.
Yogev Y., Catalano P.M. Pregnancy and Obesity // Obstet. Gynecol. Clin. N. Am. — 2009. — Vol. 36. — P. 285-300.
Qiu C., Williams M.A., Vadachkoria S. et al. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus // Obstetrics and Gynecology. — 2004. — Vol. 103. — P. 519-525.
D’Anna R., Baviera G., Cannata M.L. et al. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes // Gynecologic and Obstetric Investigation. — 2007. — Vol. 64. — P. 65-68.
McLachlan K.A., O’Neal D., Jenkins A. et al. Do adiponectin, TNF alpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy // Diabetes/Metabolism Research and Reviews. — 2006. — Vol. 22. — P. 131-138.
Ouchi N., Parker J.L., Lugus J.J. et al. Adipokines in inflammation and metabolic disease // Nature Reviews Immunology. — 2011. — Vol. 11. — P. 85-97.
Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation // Diabet Med. — 1998. — Vol. 15. — P. 539-553.
Metzger B.E., Gabbe S.G., Persson B. et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy // Diabetes Care. — 2010. — Vol. 33. — P. 676-682.
International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy // Diabetes Care. — 2010. — Vol. 33(3). — P. 676-682.
Wendland E.M., Torloni M.R., Falavigna M. et al. Gestational Diabetes and Pregnancy Outcomes. A Systematic Review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) Diagnostic Criteria. BMC Pregnancy Childbirth. — 2012. —
Samolis S., Papastefanou I., Panagopoulos P. et al. Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies — role of leptin as a marker of pre-eclampsia: a prospective case-control study // Gynecological Endocrinology. — 2010. — Vol. 26. — P. 338-343.
Ning Y., Williams M.A., Muy-Rivera M. et al. Relationship of maternal plasma leptin and risk of pre-eclampsia: a prospective study // The Journal of Maternal-Fetal and Neonatal Medicine. — 2004. — Vol. 15. — P. 186-192.
Hauguel-De Mouzon S., Lepercq J., Catalano P. The known and unknown of leptin in pregnancy // American Journal of Obstetrics and Gynecology. — 2006. — Vol. 194. — P. 1537-1545.